Wound Management News

Skin abscesses have become increasingly common, particularly in association with MRSA infection, and despite new therapeutic options, the success rate is highly variable, according to a recent review in The New England Journal of Medicine.

NEW ORLEANS – Repeat skin antisepsis performed after surgical draping but before incise draping reduces the incidence of surgical site infection in patients who undergo total joint replacement, according to results of a study presented here.

Researchers in China used a combination of subcutaneously expanded skin and bone marrow mononuclear stem cell transplantation to create larger skin flaps to repair full facial skin defects in a recent study.

Patients with inflammatory bowel disease and pyoderma gangrenosum or erythema nodosum displayed distinct clinical and genetic characteristics that may indicate shared etiologies in a recent study.

Implementing a rapid molecular diagnostic test for MRSA among patients with purulent skin infections did not reduce the empiric use of MRSA-active antibiotics for patients with non-MRSA infections, according to researchers from the University of California, Los Angeles.

XBiotech has begun a phase 2 study based on anti-interleukin-1 alpha therapeutic antibody for treating patients with pyoderma gangrenosum.

Organogenesis announced that it has acquired Dermagraft assets from Shire.

Medical technology company BD Diagnostics has received FDA clearance to market a molecular assay capable of detecting newly emerging strains of MRSA, according to a company news release.

Since the implementation of the Veterans Affairs MRSA Prevention Initiative in long-term care facilities in January 2009, the overall rate of health care-associated MRSA infections decreased by 36%, according to study findings in the American Journal of Infection Control.

Scioderm announced a phase 2b study on the efficacy and safety of its novel topical therapy for treating nonhealing wounds in patients with epidermolysis bullosa has begun.